AIG
EWTX icon

American International Group’s Edgewise Therapeutics EWTX Stock Holding History

American International Group’s Portfolio EWTX Stock Details EWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-28,418
Closed -$518K – 909
2024
Q1 		$518K Buy
28,418
+7,151
+34% +$114K ﹤0.01% 1631
2023
Q4 		$233K Sell
21,267
-86
-0.4% -$604 ﹤0.01% 2095
2023
Q3 		$122K Buy
21,353
+759
+4% +$5.16K ﹤0.01% 2397
2023
Q2 		$160K Buy
20,594
+2,300
+13% +$19.4K ﹤0.01% 2299
2023
Q1 		$122K Buy
18,294
+364
+2% +$3.37K ﹤0.01% 2365
2022
Q4 		$160K Buy
17,930
+3,817
+27% +$35.8K ﹤0.01% 2258
2022
Q3 		$139K Buy
14,113
+200
+1% +$2.02K ﹤0.01% 2371
2022
Q2 		$111K Sell
13,913
-5,297
-28% -$40K ﹤0.01% 2541
2022
Q1 		$186K Sell
19,210
-1,351
-7% -$17.4K ﹤0.01% 2286
2021
Q4 		$314K Buy
20,561
+13,568
+194% +$244K ﹤0.01% 2088
2021
Q3 		$116K Buy
6,993
+79
+1% +$1.43K ﹤0.01% 2738
2021
Q2 		$147 Buy
+6,914
New +$189K ﹤0.01% 2699

Other funds holding EWTX

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

American International Group's EWTX Position: Q2 2024 in Review

American International Group sold out of Edgewise Therapeutics (EWTX) in Q2 2024, closing a stake of 28,418 shares — an estimated $518K sold.

American International Group first reported a position in EWTX in Q2 2021 and held it in 12 quarters. The position peaked at $518K in Q1 2024. 140 funds tracked by Wall St. Rank hold EWTX as of Q2 2024.

  • American International Group reported no remaining Edgewise Therapeutics position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 28,418 Edgewise Therapeutics shares in Q2 2024, an estimated $518K.
  • American International Group first reported a position in Edgewise Therapeutics in Q2 2021 and held it in 12 quarters.
  • American International Group's Edgewise Therapeutics position peaked at $518K in Q1 2024.
  • 140 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.